Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL8134718 | 0.84 | SPHK1 (0.37) | — | |
| Methyl Alcohol SCHEMBL1300315 | 0.81 | — | — | |
| Tetrahydrofuran SCHEMBL154168 | 0.79 | — | — | |
| Isobutane SCHEMBL27712550 | 0.78 | TP53 (0.33) | ALDH1A1 | |
| Isobutanol SCHEMBL28235407 | 0.78 | TSHR (0.53) | — | |
| SCHEMBL28118855 | 0.78 | TSHR (0.35) | — | |
| Methyl Alcohol SCHEMBL5662584 | 0.77 | — | — | |
| Ethane SCHEMBL25176936 | 0.76 | — | — | |
| Tetrahydrofuran SCHEMBL2143001 | 0.76 | ALDH1A1 (0.53) | ALDH1A1LMNA | |
| Isopropyl Alcohol SCHEMBL9004332 | 0.76 | ALDH1A1 (0.53) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5310860-A | — | — | None | — | — | JP | disclosed |
| EP-3645484-B1 | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT CATALYSIS | LONZA SOLUTIONS AG (CH) | 2021-11-10 | — | — | EP | disclosed |
| US-10968187-B2 | Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis | LONZA SOLUTIONS AG (CH) | 2021-04-06 | — | — | US | disclosed |
| US-20200157063-A1 | Method for Preparation of Alkylated or Fluoro, Chloro and Fluorochloro Alkylated Compounds by Heterogeneous Cobalt Catalysis | ARXADA AG (CH) | 2020-05-21 | — | — | US | disclosed |
| EP-3645484-A1 | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT CATALYSIS | Lonza Ltd (CH) | 2020-05-06 | — | — | EP | disclosed |
| WO-2019020726-A1 | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT CATALYSIS | LONZA LTD (CH) | 2019-01-31 | — | — | WO | disclosed |
| CN-105593321-B | Coating composition, film and film steel plate | 日涂工业涂料有限公司 | 2018-11-09 | — | — | CN | disclosed |
| US-20090258275-A1 | POLYMER ELECTROLYTE, POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, AND FUEL CELL | CANON KABUSHIKI KAISHA (JP) | 2009-10-15 | — | — | US | disclosed |
| US-20080312192-A1 | Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases | BOLD GUIDO | 2008-12-18 | — | — | US | disclosed |
| EP-1689376-A2 | DIARYL UREA DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES | Novartis AG (CH) | 2006-08-16 | — | — | EP | disclosed |
| EP-1455834-A2 | POST-COATED LIPOSOME/LIPOPLEX FOR TARGETED DRUG/GENE DELIVERY AND LIPID LINKED TO A DELIVERY, TARGETING OR STABILISING MOIETY | Mitsubishi Chemical Corporation (JP) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003047549-A2 | POST-COATED LIPOSOME/LIPOPLEX FOR TARGETED DRUG/GENE DELIVERY AND LIPID LINKED TO A DELIVERY, TARGETING OR STABILISING MOIETY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-12 | — | — | WO | disclosed |
| EP-0350014-B1 | Volume phase type hologram and method of manufacture thereof | CANON KK (JP) | 1998-10-14 | — | — | EP | disclosed |
| EP-0349982-B1 | Volume phase type hologram film and photosensitive resin composition employed therefor | CANON KK (JP) | 1994-10-12 | — | — | EP | disclosed |
| JP-H05310860-A | MATERIAL FOR INTRAOCULAR LENS | KOWA CO | 1993-11-22 | — | — | JP | disclosed |
| US-5240795-A | Volume phase type hologram film and photosensitive resin composition employed therefor | CANON KABUSHIKI KAISHA (JP) | 1993-08-31 | — | — | US | disclosed |
| US-5231520-A | VOLUME PHASE TYPE HOLOGRAM AND METHOD OF MANUFACTURE THEREOF | CANON KABUSHIKI KAISHA (JP) | 1993-07-27 | — | — | US | disclosed |
| EP-0350014-A2 | Volume phase type hologram and method of manufacture thereof | CANON KABUSHIKI KAISHA (JP) | 1990-01-10 | — | — | EP | disclosed |
| EP-0349982-A2 | Volume phase type hologram film and photosensitive resin composition employed therefor | CANON KABUSHIKI KAISHA (JP) | 1990-01-10 | — | — | EP | disclosed |
| US-4053312-A | O-SULFONAMIDONAPHTHOL DIFFUSIBLE DYE IMAGE PROVIDING COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968187-B2 | Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis | ABL1, CAT, MYC | ALDH1A1 2080/4885LMNA 3178/4885 |
| US-20080312192-A1 | Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases | RET, PRKDC, PRKACA | ALDH1A1 3290/4885LMNA 2847/4885 |
| US-20200157063-A1 | Method for Preparation of Alkylated or Fluoro, Chloro and Fluorochloro Alkylated Compounds by Heterogeneous Cobalt Catalysis | ABL1, CAT, MYC | ALDH1A1 2080/4885LMNA 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.